baber/WOPTO huggingface dataset:
Patent AU-2019480892-A1 (AU)
Title: Method and system for treating fluid and flotation arrangement
Inventor: KAUPPI JANNE
IPC: B01F23/20
Filed: 2019-12-31
Abstract: Described is a method and a system for treating fluid (3). The method comprises a fluid feeding step for feeding fluid (3) in a fluid feeding pipe (1) into a fluid reactor vessel (2), a bubbles feeding step for feeding bubbles of first fluid mixture (4) containing first carrier fluid and first active fluid into fluid (3) flowing in the fluid feeding pipe (1) by means of a sparger apparatus (5). The method comprises a fluid mixture analyzing step for measuring the relative content of first active fluid in the first fluid mixture (4) with a first fluid analyzer (22) and controlling a first active fluid source (23) with the first fluid analyzer (22) in response to the relative content of first active fluid in the first fluid mixture (4) as measured by the first fluid analyzer (22).
Patent AU-2020201902-A1 (AU)
Title: Ligature resistant floor drain and grate
Inventor: BOELTL DARRYL M
IPC: E03F5/04
Filed: 2020-03-16
Abstract: LIGATURE RESISTANT FLOOR DRAIN AND GRATE 
ABSTRACT 
A strainer (62) for a ligature resistant floor drain (10) and a ligature resistant floor drain (10) 
incorporating a strainer (62). The strainer (62) includes a top plate (72) with two sets of 
openings (94, 96) forming rings. A cylindrical extension (84) extends from the top plate (72) at 
a location between the rings. Also provided are two series of webs (92), each web of which is 
located between an adjacent pair of openings in one of the rings. Optionally, a strainer plate (64) 
is attached to the cylindrical extension (84) and extends at least one of radially inward and 
outward relative from the cylindrical extension (84). The floor drain (10) further includes a 
strainer frame (18) having a receptacle (31) into which the strainer (62) is received.
1/4 
1 /14 
10 94 ----- -9- 96 60 
96 9 
/ - s72 
76 74 
12 
96 96 
ll' 
Ag 94 
56 
60
80 9 6 -
FIG. 1 
13 
44 49 50 52 20 6054 
- - - - - - -- 56 
--- 58 
39 
4 38 
32 
16 
36 
18 34 
15 
40 
43 28 
26 48 
31 46 
30 
41 4 
14--'- ~4 
24 FIG. 2
Patent AU-2020204321-A1 (AU)
Title: Support bracket for a rope
Inventor: COMBRINK JAN RASMUS
IPC: E21F11/00
Filed: 2020-06-29
Abstract: The invention relates to a support bracket for a rope, the support bracket including an 
elongate body made from arcuately curved round bar which is configured to be mounted to 
5 a wall by way of mounting brackets provided at opposite ends of the round bar and a rope 
guide, configured to receive or hold the rope, connected to the elongate body. The rope guide 
is longitudinally displaceable relative to the body between an inoperative upper condition 
and an operative lower condition. A retaining means in the form of a magnet is provided at 
an operatively upper end of the elongate body in order releasably to hold the rope guide in 
.0 its inoperative upper condition.
1/12 
10.1 
18 16 22 
28 
26 24 
14 
12 
22 
20 
16 Figure 1
Patent AU-2020204638-A1 (AU)
Title: A vacuum assembly
Inventor: BOXSELL TRACY
IPC: B01D45/12
Filed: 2020-07-10
Abstract: AVACUUMASSEMBLY 
ABSTRACT 
A vacuum assembly (1) having a pump adapted to produce a suction airstream through 
the assembly, the vacuum assembly (1) including: a suction nozzle (5) adapted to be moved by a 
user about an operation site to remove particles from the site; a first chamber (10) connected to 
the nozzle (5) by a first duct (7) and adapted to remove large particles from the airstream; a 
second chamber (30) connected to the first chamber (10) by a second duct (42) and adapted to 
receive medium particles from the airstream; a third chamber (40) connected to the second 
chamber (30) by a third duct (51) and adapted to remove fine particles from the airstream; a fine 
filter (60) connected to the third chamber (40) by a fourth duct (61) and adapted to remove very 
fine particles from the airstream; and an exhaust (74) to outlet the airstream from the assembly 
(1).
1/2 
0 
0 
h-r0 
000 
Do 
00 
00O 
00 
D00 
00 
a0 
D00 
0 
D0 
00 
00 
000 
000000O 0 
00000000 
00000000 
t0
Patent AU-2020217729-A1 (AU)
Title: Enhanced smoking product
Inventor: COOPER JEFFREY T
IPC: A24D1/02
Filed: 2020-02-05
Abstract: A smoking product using splined leaves, such as cannabis/hemp leaves, orientated and configured to achieves a unique cylindrical/tubular structure wherein the splines (e.g., the veins of a leaf structure) are arranged to achieve a burning chamber that creates a non-laminar airflow resulting in an enhanced burning environment.
Patent AU-2020223228-A1 (AU)
Title: Compounds, compositions and methods
Inventor: CRAIG II ROBERT A
IPC: A61K31/415
Filed: 2020-02-12
Abstract: The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.
Patent AU-2020242032-A1 (AU)
Title: Methods and compositions for editing nucleotide sequences
Inventor: LIU DAVID R
IPC: C12N15/11
Filed: 2020-03-19
Abstract: The present disclosure provides new prime editor guide RNAs for prime editing, constructs for prime editing, and methods for using same. In addition, the present disclosure provides compositions and methods for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and/or targeted mutagenesis (e.g., insertion or deletion). The nucleotide change can include a single-nucleotide change (e.g., any transition or any transversion), an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a prime editor RNA (PEgRNA). The prime editor guide RNA comprises an extension arm that provides a DNA synthesis template sequence which encodes a single strand DNA flap, which is homologous to an endogenous DNA sequence, but which contains the desired one or more nucleotide changes and which, following synthesis by the polymerase (e.g., reverse transcriptase), becomes incorporated into the target DNA molecule.
Patent AU-2020299074-A1 (AU)
Title: Novel ribonucleic acid and pharmaceutical composition based on the same
Inventor: KIM DONG HO
IPC: C12N15/113
Filed: 2020-07-01
Abstract: The present invention relates to a hetero-structured RNA (hsRNA) comprising an ssRNA and a dsRNA, wherein the dsRNA has any length and sequence, has complete complementarity, acts as a TLR3 ligand, and is located in the middle of hsRNA, and wherein the ssRNA has any sequence (preferably, TLR7 ligand sequence) and can have certain length and is linked to both 3' ends of the dsRNA. In addition, the present invention relates to pharmaceutical compositions comprising the same for preventing and treating a viral or bacterial infection and cancer.
Patent AU-2020303728-A1 (AU)
Title: Cementitious reagents, methods of manufacturing and uses thereof
Inventor: LAKE DONALD
IPC: C04B7/44
Filed: 2020-06-29
Abstract: Described are cementitious reagent materials produced from globally abundant inorganic feedstocks. Also described are methods for the manufacture of such cementitious reagent materials and forming the reagent materials as microspheroidal glassy particles. Also described are apparatuses, systems and methods for the thermochemical production of glassy cementitious reagents with spheroidal morphology. The apparatuses, systems and methods makes use of an in-flight melting/quenching technology such that solid particles are flown in suspension, melted in suspension, and then quenched in suspension. The cementitious reagents can be used in concrete to substantially reduce the CO
Patent AU-2020325632-A1 (AU)
Title: Locknut
Inventor: FLAIG HARTMUT
IPC: F16B39/282
Filed: 2020-07-30
Abstract: The invention relates to a locknut having a nut body (12), which has a threaded portion with inner thread (16), a peripheral shoulder (20) adjoining the latter, and a collar surrounding the shoulder, and having an annular disc (22) made of metal, wherein the annular disc rests on the shoulder inside the collar, and the collar is bent inward in order to form, between the bent collar and the shoulder, an annular groove (28) in which the annular disc is received. An inner thread (16') corresponding to the inner thread of the threaded portion of the nut body is cut into the inner circumference of the annular disc, and the inner thread of the annular disc is offset at an axial distance with respect to the inner thread of the nut body. A row of axially protruding projections (40, 44, 60', 60'') and/or depressions (54) is formed on the shoulder or on the annular disc, at the place where the annular disc and the shoulder overlap each other.
Patent AU-2020379757-A1 (AU)
Title: Methods of treatment with antibodies against BCMA and CD3
Inventor: BURGESS MICHAEL
IPC: A61P35/02
Filed: 2020-11-04
Abstract: The present invention relates to methods of treating a patient having a disorder associated with BCMA expression (e.g. BCMA-expressing B-cell cancers, such as multiple myeloma) using dose-escalation dosing regimens with multispecific (e.g. bispecific) antibodies that bind to CD3 and BCMA.
Patent AU-2020386443-A1 (AU)
Title: Flame retardants for battery electrolytes
Inventor: GE ZHONGXIN
IPC: H01M50/00
Filed: 2020-11-18
Abstract: This invention provides nonaqueous electrolyte solutions for lithium batteries. The nonaqueous electrolyte solutions comprise a liquid electrolyte medium; a lithium- containing salt; and at least one oxygen-containing brominated flame retardant.
Patent AU-2020386473-A1 (AU)
Title: Compositions comprising bacterial strains
Inventor: MULDER Imke Elisabeth
IPC: A61P3/00
Filed: 2020-05-18
Abstract: The invention provides compositions comprising a bacterial strain of the genus
Patent AU-2020393384-A1 (AU)
Title: Substituted aminoquinolones as DGKalpha inhibitors for immune activation
Inventor: SCHMEES NORBERT
IPC: C07D403/04
Filed: 2020-11-24
Abstract: The present invention covers aminoquinolone compounds of general formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8 and n are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of diacylglycerol kinase alpha regulated disorders, as a sole agent or in combination with other active ingredients.
Patent AU-2020401277-A1 (AU)
Title: Unitary lateral leg with three or more openings
Inventor: STEELE DAVID JOE
IPC: E21B17/18
Filed: 2020-12-10
Abstract: Provided is a multilateral leg bore, a multilateral junction, and a well system. The multilateral leg bore, in one aspect, includes a unitary housing having a first end and a second opposing end defining a length (L). In accordance with this aspect, the multilateral junction includes three or more bores formed in the housing and extending along the length (L).
Patent AU-2020413633-A1 (AU)
Title: Compositions and methods for treating autoimmune diseases and cancers by targeting IGSF8
Inventor: LIU XIAOLE
IPC: A61K39/005
Filed: 2020-12-24
Abstract: Methods and compositions are provided. The methods and compositions are used for treating a cancer, and/or an autoimmune disease, by modulating the expression and / or activity of IGSF8 and its binding ligands. The pharmaceutical compositions may include, but are not limited to, antibodies that specifically bind human IGSF8, and have an activity of inhibiting IGSF8-mediated immunosuppression in a subject in need thereof.
Patent AU-2020414040-A1 (AU)
Title: Cancer treatment method and medicine
Inventor: KOBAYASHI KUNIHIKO
IPC: A61K35/74
Filed: 2020-12-25
Abstract: The present disclosure provides a composition, a combination product, a medical device and the like for treating or preventing cancer or a tumor or preventing the recurrence of the cancer or the tumor. The present disclosure provides a composition, a combination product and a medical device for treating or preventing cancer or a tumor or preventing the recurrence of the cancer or the tumor, each of which comprises an immune checkpoint inhibitor and a dendritic cell direct activator or means. In another aspect, the present disclosure provides: a novel cancer treatment method which comprises carrying out a treatment of cancer by employing a combination of a treatment by the administration of an immune checkpoint inhibitor and a treatment for improving the sensitivity to the immune checkpoint inhibitor and, therefore, can be used as an immunotherapy that can be expected to have an excellent therapeutic effect; and a medicine which can be used for the cancer treatment method.
Patent AU-2020475821-A1 (AU)
Title: Device and method for integrating hair extensions
Inventor: BANCIC MARIE
IPC: A41G5/00
Filed: 2020-12-04
Abstract: A hair extension comprising plurality of bands having hair wefts secured thereto with micro loops adhered between the plurality of bands for attachment to the wearer's native hair. A first band has a front side and a back side and an extension weft is attached to either the front side or the backside, or both, micro links are attached with adhesive. A second band has a front side and a back side and may also have an extension weft attached to either the front side or the back side or both. Micro links are secure to either the back side of the first band or the back side of the second band, or both.
Patent WO-2021168503-A1 (WO)
Inventor: GLEESON SHAUN
IPC: C14B1/40
Filed: 2021-02-04
Abstract: A hide processing system for processing hides, including a container adapted to contain a treating liquid to treat hides, and one or more ultrasonic transducers associated with the container, wherein in use, the one or more ultrasonic transducers generate ultrasonic waves in the treating liquid to treat the hides.
Patent AU-2021200553-A1 (AU)
Title: Embolus removal device with blood flow restriction and related methods
Inventor: MA JIANLU
IPC: A61B17/221
Filed: 2021-01-29
Abstract: A clot removal device has an expandable treatment member having a distal tip and a 
proximal end, a delivery wire having a distal end coupled to the proximal end of the 
expandable treatment member, and a flow restrictor carried along the delivery wire at 
a location that is separate and proximal from the expandable treatment member. The 
flow restrictor has a body with a distal section and a proximal section, the distal 
section being covered and the proximal section being uncovered. The expandable 
treatment member is moveable relative to the flow restrictor, and can be retracted 
into the distal section.
7/7 
/224 ~3 
264 ~ 
FIG. 15A 
224 
24 
FIG,.15C
Patent AU-2021201135-A1 (AU)
Title: 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative
Inventor: KATOH TAKAHIRO
IPC: A61K31/50
Filed: 2021-02-22
Abstract: The present invention provides an agent for treating 
malignant tumor, comprising a compound of formula (1): 
R2 
R   O-Y-OH 
N 
HN R4 
R3 
0 CH3 
5 
wherein R' to R 4 are hydrogen atom, halogen, or etc., Y is 
optionally-substituted alkylene group or etc.
Patent AU-2021201973-A1 (AU)
Title: Cartridge and electrophotographic image forming apparatus
Inventor: NISHIDA SHINICHI
IPC: G03G21/18
Filed: 2021-03-30
Abstract: CARTRIDGE AND ELECTROPHOTOGRAPHIC 
IMAGE FORMING APPARATUS 
ABSTRACT 
A control member 76 for controlling transmission and blocking of a 
rotational force by a clutch is rotatably supported by a supporting member which 
supports a developing frame. a locking portion provided on the control member 
5 76 rotates between a position retracted from a locked portion of the clutch and a 
position for engaging with the locked portion.
Patent AU-2021203336-A1 (AU)
Title: Improved polyethyleneimine polyethyleneglycol vectors
Inventor: LEVITZKI ALEX
IPC: A61K47/34
Filed: 2021-05-24
Abstract: A polyplex of a double stranded RNA and a polymeric conjugate is provided, wherein the 
polymeric conjugate consists of a linear polyethyleneimine covalently linked to one or more 
polyethylene glycol (PEG) moieties, each PEG moiety being conjugated via a linker to a 
targeting moiety capable of binding to a cancer antigen.  
48 
17706804_1 (GHMatter) P42431AU01
Patent AU-2021223191-A1 (AU)
Title: Compositions and therapeutic uses of cannabidiol
Inventor: PATEL MANIT
IPC: A61K36/185
Filed: 2021-02-19
Abstract: The invention provides various pharmaceutical composition comprising the new therapeutic agent cannabidiol that rescues the adversely affected sodium channels Nav1.5 and thus serves as a potential therapeutic agent for treating several cardiac disorders. The invention also provides various pharmaceutical composition employing the new therapeutic agent cannabidiol for abolishing or minimizing side effects of other therapeutic agents / drugs which induce, or which are likely to induce Long QT. The invention further provides pharmaceutical composition of cannabidiol for treating or avoiding inflammation induced by any other therapeutic agent or inflammation induced in any diseases or ailment such as Covid-19 and also inflammation induced by any vaccine such as Covid-19 vaccine.
Patent AU-2021229402-A1 (AU)
Title: Automatic test card for multi-blood group system and test method
Inventor: LUO YANG
IPC: G01N33/80
Filed: 2021-03-03
Abstract: Disclosed are an automatic multi-blood-group system test card and test method. The automatic multi-blood-group system test card comprises, from top to bottom, a sample adding layer, a reaction layer, a color developing layer and an identification layer, wherein the sample adding layer is provided with a sample adding hole (1); the reaction layer is provided with a whole blood pad (3) or a filter pad (2) which filters red blood cells from whole blood; the bottom of the sample adding hole (1) is connected to the whole blood pad (3) or the filter pad (2); the end of the whole blood pad (3) is connected to several antibody pads (4) precoated with blood group antibodies; the end of the filter pad (2) is connected to an antigen pad (6) precoated with blood group antigens by means of a delay pad (5); the reaction layer is independently provided with a quality control strip; the color developing layer is provided with several color developing areas connected to the end of the antibody pad (4) or the antigen pad (6); and the identification layer is in a reverse connection with the color developing layer. According to the automatic multi-blood-group system test card and test method, the blood group test is combined with coding technology to rapidly test various blood groups, achieve automatic identification of various blood groups, reduce manual determination errors, improve the test efficiency, omit special apparatuses, and achieve a rapid, accurate, automatic and portable blood group test.
Patent AU-2021232839-A1 (AU)
Title: Updating Attribute Data Structures to Indicate Trends in Attribute Data Provided to Automated Modelling Systems
Inventor: OUYANG JEFFREY Q
IPC: G06F16/10
Filed: 2021-09-17
Abstract: A server system is disclosed, comprising: a non-transitory computer-readable medium storing a 
data structure, the data structure having training data for training an automated modelling 
algorithm, the training data comprising data items for a set of attribute values for multiple 
entities over a time period, wherein each data item in the training data indicates (i) a respective 
attribute value for at least one attribute, (ii) a respective time value within the time period, and 
(iii) a respective entity associated with the respective attribute value; and a processing device 
communicatively coupled to the non-transitory computer-readable medium, wherein the 
processing device is configured for performing operations comprising: generating, for each 
entity, at least one trend attribute that is a function of a respective time series of attribute values 
from the set of attribute values, the at least one trend attribute indicating a trend in the time series 
of attribute values, wherein generating the at least one trend attribute comprises: generating 
multiple cluster series, wherein each cluster series comprises clusters respectively associated 
with intervals of the time period and attribute values associated with time values in the intervals, 
and computing, for the multiple cluster series, respective behavioural attribute values, wherein 
each behavioural attribute value is computed as a function of the respective cluster series; 
updating the training data to include trend attribute values of the at least one trend attribute for 
the respective entities, wherein updating the training data comprises, for at least some of the 
entities in the training data: identifying, for each entity, a respective cluster series having a 
respective behavioural attribute value that is similar to a respective behaviour of a respective 
time series of attributes values for the entity, assigning a cluster membership to the entity based 
on the respective behavioural attribute value being similar to the respective behaviour of the 
respective time series of attributes values for the entity, and selecting, for the entity, an identifier 
of the cluster membership as a trend attribute value for the entity; and training the automated 
modelling algorithm with the trend attribute values to generate a trained automated modelling 
algorithm, wherein the automated modelling system is configured to use the trained automated 
modelling algorithm for performing one or more risk assessments.
Patent AU-2021245102-A1 (AU)
Title: Variants derived from ActRIIB and uses therefor
Inventor: KNOPF JOHN
IPC: C07K14/705
Filed: 2021-10-05
Abstract: In certain aspects, the present invention provides compositions and methods for modulating 
(promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, and/or 
neuronal tissue. The present invention also provides methods of screening compounds that 
modulate activity of an ActRIIB protein and/or an ActRIIB ligand. The compositions and 
methods provided herein are useful in treating diseases associated with abnormal activity of an 
ActRIIB protein and/or an ActRIIB ligand.
Patent AU-2021250741-A1 (AU)
Title: Face and head shield
Inventor: RANSON ROBERT
IPC: A61F9/04
Filed: 2021-03-30
Abstract: A protective shield features a single-piece transparent dome or shell having a rear opening through which facial and cranial regions of a user's head are received, thereby providing improved coverage over conventional face shields that cover the face only. Inward protrusions at a transitional region between the facial and cranial portions of the shield rest against the forehead to offset the facial portion of the shield forwardly of the user's face to allow airflow, optionally introduced from an external fan via an airflow channel integrally formed in the cranial portion. A flexible connector clip has a J-shaped profile for engaging an out-turned flange around the boundary of the shield' s rear opening, to enable clipped connection of a bib or shroud. Support protrusions in an underside of the cranial portion maintain airspace above the head, which is further optimized by a rearwardly sloped incline of the cranial portion.
Patent AU-2021268335-A1 (AU)
Title: Pharmaceutical and cosmetic compositions comprising secretomes
Inventor: LEE JAU-NAN
IPC: G01N33/50
Filed: 2021-05-04
Abstract: Disclosed are pharmaceutical or cosmetic compositions comprising secretomes, for example secreted proteins from stem cells, and uses thereof. A composition that contains a secretome and an acceptable excipient may be free of a cell. The compositions are useful for inducing an immune response, treating an inflammatory response, treating a microbial infection, differentiating cells, wound healing, embryonic development, placental development, central nervous system development, or morphogenesis.